ARWR - Arrowhead Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$105.17
DETAILS
HIGH:
$126.00
LOW:
$46.00
MEDIAN:
$117.50
CONSENSUS:
$105.17
UPSIDE:
23.86%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 431,560 | $35.2M | 0.0% | -752,278 | DECREASED |
| Wood | 15,400 | $1.3M | 0.0% | +3,900 | INCREASED |
| Greenblatt | 6,696 | $545,791 | 0.0% | -31,472 | DECREASED |
| Dalio | 0 | $0 | -- | -95,552 | SOLD |
| Laffont | 0 | $0 | -- | -3,797 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-18 | OLUKOTUN ADEOYE Y | director | SELL | 2,000 | $86.96 | $174K |
| 2026-08-18 | PERRY MICHAEL S | director | SELL | 11,600 | $87.30 | $1.0M |
| 2026-06-15 | Cohen Matthew Gregory | director | A-Award | 11,882 | -- | -- |
| 2026-06-15 | Cohen Matthew Gregory | director | ? | -- | -- | -- |
| 2026-05-12 | Lu Hongbo | director | SELL | 2,970 | $76.88 | $228K |
| 2026-04-22 | Apel Daniel Joseph | officer: Chief Financial Officer | SELL | 3,208 | $70.11 | $225K |
| 2026-04-22 | Apel Daniel Joseph | officer: Chief Financial Officer | SELL | 1,157 | $70.45 | $82K |
| 2026-04-22 | Apel Daniel Joseph | officer: Chief Financial Officer | SELL | 8,730 | $71.92 | $628K |
| 2026-04-23 | Hamilton James C | officer: Chief Medical Officer | SELL | 10,000 | $75.00 | $750K |
| 2026-03-05 | Hamilton James C | officer: Chief Medical Officer | SELL | 10,000 | $64.19 | $642K |
| 2026-01-06 | Hamilton James C | officer: Chief Medical Officer | A-Award | 75,000 | -- | -- |
| 2026-01-06 | Apel Daniel Joseph | officer: Chief Financial Officer | A-Award | 75,000 | -- | -- |
| 2026-01-06 | O'Brien Patrick | officer: COO | G-Gift | 540 | -- | -- |
| 2026-01-06 | O'Brien Patrick | officer: COO | G-Gift | 440 | -- | -- |
| 2026-01-06 | O'Brien Patrick | officer: COO | A-Award | 75,000 | -- | -- |
| 2026-01-05 | Hamilton James C | officer: Chief Medical Officer | SELL | 309 | $68.00 | $21K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 4,368 | $61.20 | $267K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 6,164 | $62.23 | $384K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 13,451 | $62.96 | $847K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 11,842 | $63.84 | $756K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 2,700 | $64.44 | $174K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 600 | $61.12 | $37K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 900 | $62.25 | $56K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 2,336 | $64.04 | $150K |
| 2026-01-05 | O'Brien Patrick | officer: COO | SELL | 46 | $68.00 | $3K |